However, IDH2 mutations are found in only 20–30% of AITL cases, and other AITL cases without IDH2 mutations, mainly the C1 subtype, can also have increased angiogenesis. This evidence concerns the gene IDH2 and angioimmunoblastic T-cell lymphoma.